Skip to Main Content
Oncology CRO Services
Full Service CRO
Clinical Analytics
Site Network
Consulting
Development Phase
Early Phase Research Catalyst Oncology, an oncology clinical research organization, works with innovative biotechs on a range of early phase study designs and therapies.
Late Phase Research Catalyst Oncology helps move oncology therapies through the complex and dynamic clinical trial environment with workable solutions, best-in-class technologies, and a data-centric approach.
Information Sheet
Immuno-Oncology
Helping to bring immunotherapies to cancer patients in need
Read more
Insights
Contact Us
Oncology CRO Services
Full Service CRO
Clinical Analytics
Site Network
Consulting
Development Phase
Early Phase ResearchCatalyst Oncology, an oncology clinical research organization, works with innovative biotechs on a range of early phase study designs and therapies.
Late Phase ResearchCatalyst Oncology helps move oncology therapies through the complex and dynamic clinical trial environment with workable solutions, best-in-class technologies, and a data-centric approach.
Information Sheet
Immuno-Oncology
Helping to bring immunotherapies to cancer patients in need
Read more
Insights
Contact Us
Category: Biotech
Case Study Accelerating Approval Pathway For Phase III Ovarian Cancer Trial A late-stage biotech was developing a combination therapy for a rare form of ovarian cancer. It is challenging to diagnose, difficult to treat due to its chemo-resistance, and at the time, there were no approved treatments specifically for this indication. Read Now Blog Highlights from Clinical Trials in Oncology East Coast 2025 From Protocol Design to Partnerships Earlier this month, I had the privilege of chairing the Clinical Read Now Blog Artificial Intelligence in Oncology Clinical Trials Transforming drug development Artificial intelligence (AI) is revolutionizing nearly every aspect of our work and Read Now Case Study Focused Monitoring Support for Rare Disease Study A small biotech needed functional support for a Phase III rare disease study. Although a contract existed between the biotech and a clinical research organization (CRO), the study timelines and budget had slipped. The biotech hired Catalyst Flex to reverse that trend and ultimately saved ~$1 million. Read Now Person at a computer with a bar chart being designed with a stylus. Blog Impacts of Project Optimus on Oncology Trial Costs Exploring creative financial solutions for biotechs Navigating the evolving landscape of early-phase drug development has Read Now A smiling Keya Watkins gesturing at a podium at Clinical Trials in Oncology. Blog Navigating the Changing Landscape of Clinical Trials Takeaways from the Clinical Trials in Oncology East Coast I was thrilled to recently chair Read Now Blog Policy Changes from Patient Support to Location BIO International 2024 Highlights Biotech companies from all over the globe, including those researching novel, Read Now Graphic of Benefits of Working with Catalyst Oncology versus a large generalist CRO with an image of two people bathed in sunshine. Article Benefits of Working with Catalyst Oncology versus a Large Generalist CRO Oncology drug development continues to increase in its complexity. Large contract research organizations (CROs) are Read Now Case Study Providing Support to Succeed Catalyst Flex delivers clinical monitoring oversight experts on Phase III global study Situation A small Read Now Webinar Webinar: Clinical Trial Flexibility and Customization Needs that Are Required by Biotechs and Next-generation Therapies COVID-19 has ushered in new challenges when conducting clinical trials, but mid-tier biotech companies have Read Now
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.